会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Heteroarylethylamine as production promoters in livestock
    • 杂环三乙胺作为家畜生产促进剂
    • US4863939A
    • 1989-09-05
    • US80284
    • 1987-07-30
    • Hans LindelWerner HallenbachFriedrich BerschauerAnno de JongMartin Scheer
    • Hans LindelWerner HallenbachFriedrich BerschauerAnno de JongMartin Scheer
    • C07D213/84A23K20/132A61K31/44A61K31/4402A61K31/4412A61K31/4418A61P15/00C07D213/36C07D213/38C07D213/61C07D213/70C07D213/72C07D213/73C07D213/74C07D213/75C07D213/79C07D213/81
    • C07D213/73A23K20/132C07D213/38C07D213/61
    • The growth of livestock is promoted by the new compounds of the formula ##STR1## in which R.sup.1 represents hydrogen, alkyl, halogen, halogenoalkyl, hydroxyl, cyano, alkoxycarbonyl, aminocarbonyl, mono- and dialkylaminocarbonyl, alkoxy, halogenoalkoxy, halogenoalkylthio or NHSO.sub.2 -alkyl,R.sup.2 represents hydrogen, hydroxyl, alkoxy or the --NR.sup.11 R.sup.12 radical,R.sup.3 represents the radicals mentioned in the case of R.sup.1R.sup.4 represents hydroxyl, acyloxy or alkoxy,R.sup.5 represents hydrogen or alkyl,R.sup.6 represents hydrogen or alkyl,R.sup.7 represents hydrogen or alkyl,R.sup.8 represents hydrogen or alkyl,X represents C.sub.1 -C.sub.10 -alkylene or a direct bond,Y represents oxygen or a direct bond,R.sup.9 represents hydrogen, C.sub.1 -C.sub.10 -alkyl which is optionally substituted by hydroxyl, alkoxy, acyloxy or the --NR.sup.13 R.sup.14 radical, or represents the COR.sup.15 radical or the O--Z--R.sup.16 radical,Z represents C.sub.1 -C.sub.10 -alkylene, C.sub.1 -C.sub.10 -alkenylene or C.sub.1 -C.sub.10 -alkinylene,R.sup.10 represents hydrogen, halogen, alkyl, alkoxy, hydroxyl or the COR.sup.15 radical,R.sup.11 represents hydrogen or alkyl,R.sup.12 represents hydrogen, alkyl, halogenoalkyl or acyl,R.sup.13 represents hydrogen, optionally substituted alkyl or optionally substituted aryl,R.sup.14 represents the radicals mentioned in the case of R.sup.13,R.sup.15 represents hydroxyl, alkoxy or the NR.sup.13 R.sup.14 radical, andR.sup.16 represents hydroxyl, alkoxy, acyloxy, the NR.sup.13 R.sup.14 radical or the COR.sup.15 radical,and the physiologically acceptable salts and N-oxides thereof. Several new intermediates are also disclosed.
    • 新型化合物“IMAGE”促进了家畜的生长,其中R1代表氢,烷基,卤素,卤代烷基,羟基,氰基,烷氧基羰基,氨基羰基,一烷基氨基羰基和二烷基氨基羰基,烷氧基,卤代烷氧基,卤代烷硫基或NHSO2-烷基 ,R 2表示氢,羟基,烷氧基或-NR 11 R 12基团,R 3表示在R 4表示羟基,酰氧基或烷氧基的情况下提及的基团,R 5表示氢或烷基,R 6表示氢或烷基,R 7表示氢或烷基, R8表示氢或烷基,X表示C1-C10-亚烷基或直接键,Y表示氧或直接键,R9表示氢,任选被羟基,烷氧基,酰氧基或-NR13R14基团取代的C1-C10-烷基 ,或表示COR15基团或OZ-R16基团,Z表示C1-C10-亚烷基,C1-C10亚烯基或C1-C10亚烯基,R10表示氢,卤素,烷基,烷氧基,羟基或COR15基,R11 代理人 R12表示氢,烷基,卤代烷基或酰基,R13表示氢,任选取代的烷基或任选取代的芳基,R 14表示在R 13的情况下提及的基团,R 15表示羟基,烷氧基或NR 13 R 14基,R 16 表示羟基,烷氧基,酰氧基,NR 13 R 14基或COR 15基,及其生理上可接受的盐和N-氧化物。 还披露了几个新的中间体。
    • 10. 发明授权
    • Chromanone derivatives
    • 色酮衍生物
    • US4261988A
    • 1981-04-14
    • US20119
    • 1979-03-13
    • Arno WiddigHans-Joachim KabbeMartin ScheerRudiger Sitt
    • Arno WiddigHans-Joachim KabbeMartin ScheerRudiger Sitt
    • A61K31/35A61K31/352A61P19/06C07D311/22C07D311/24C07D311/32C07D311/92C07D311/96C07D405/04C07D491/10C07D491/107
    • C07D491/10C07D311/22C07D311/24C07D311/32C07D311/92C07D311/96
    • Compounds useful in the treatment of cholesterolaemia are of the general formula ##STR1## or salts thereof in which R.sup.1 and R.sup.2 independently denote radicals including hydrogen, alkyl, aryl and heterocyclic radical or together complete a carbocyclic or heterocylic ring, R.sup.3 denotes a radical ##STR2## in which R.sup.9, R.sup.10 and R.sup.11 include hydrogen, cyano, nitro, alkyl and aryl or, in pairs, complete carbocyclic rings, X denotes cyano, nitro or substituted carbonyl, sulphonyl or phosphonyl group, R.sup.4 is hydrogen or a radical defined for R.sup.1 or R.sup.3, and R.sup.5, R.sup.6, R.sup.7 and R.sup.8 include hydrogen, nitro, cyano, carboxyl, alkyl and aryl or, in pairs, complete carbocyclic rings, with the proviso that R.sup.1 and R.sup.9 are not both phenyl if X denotes CO--C.sub.6 H.sub.6. The compounds exhibit considerably higher hypocholesterolaemic activity than the known clofibrate and in addition exhibit a pronounced nutritive effect, e.g., in a medicated fodder or premix.
    • 用于治疗胆固醇血症的化合物具有通式(I)或其盐,其中R 1和R 2独立地表示包括氢,烷基,芳基和杂环基团的基团,或者一起完成碳环或杂环,R3表示 其中R9,R10和R11包括氢,氰基,硝基,烷基和芳基,或成对地成为完全碳环,X表示氰基,硝基或取代的羰基,磺酰基或膦酰基,R4是氢或基团 对于R 1或R 3而言,R 5,R 6,R 7和R 8包括氢,硝基,氰基,羧基,烷基和芳基,或成对地成为完全碳环,条件是如果X表示CO,则R 1和R 9不是苯基 -C6H6。 化合物显示比已知的氯贝特明显更高的降血胆固醇血症活性,并且还显示出明显的营养作用,例如在药物饲料或预混物中。